Back to search results

Elix Cycle Balance & Elix Daily Harmony for Fibroid Symptoms

This study is looking at how two herbal supplements, Elix Cycle Balance and Elix Daily Harmony, might help women with uterine fibroid (non-cancerous growths in the uterus) symptoms. You could be eligible if you are a woman between 20 and 45 years old, have a prior diagnosis of uterine fibroids, and experience moderate to severe discomfort during your period. The study aims to see if these supplements can reduce the severity of fibroid-related symptoms over 24 weeks. The current status of this study is unclear, and it plans to enroll 42 participants.

Study design
This is a 24-week, single-arm, open-label study, meaning all 42 participants will receive the supplements, and everyone will know what they are taking.
What's involved
You would take the Elix Daily Harmony and Elix Cycle Balance supplements daily and complete questionnaires at scheduled times over 24 weeks.
Compensation
Not stated in the trial record.
Follow-up
Your symptoms will be measured at Baseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07078682

An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms

Recruiting
NAAges 20–45InterventionalTreatment
Zenchi, Inc.
~42 participants
Updated 2025-09-12 on ClinicalTrials.gov
What's tested:Elix Daily Harmony

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in uterine fibroid-related symptom severity
Measured over Baseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24

Conditions

Uterine Fibroids
Leiomyoma
Menstrual Pain

Explore related trials

DysmenorrheaUterine Corpus Leiomyoma

NCT07078682

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Citruslabs

    Las Vegas, Nevadastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Patrick Renner, MSc
[email protected]
4242450284
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Be female.
Be aged 20-45.
BMI 18.5 - 24.9 kg/m2
Self-reported prior diagnosis of uterine fibroids.
Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
Self-reported moderate to severe discomfort during menstruation, related to pelvic cramps, bloating, mood swings, or fatigue.
Self-reported menstrual cramps during their cycle, for the past six months minimum.
If taking hormonal birth control, has been doing so consistently for at least three months, and experiences a menstrual cycle with a period.
If taking other oral over-the-counter supplements or herbal remedies, has been consistently taking these for at least three months prior to starting the study, and is willing to maintain this routine for the study duration.
Willing to refrain from introducing any products or any new forms of medication or supplements for the study duration.
Willing to refrain from any other dietary supplements or herbal remedies targeting the menstrual cycle during the study period.
Willing to refrain from any new vaccines during the 6 month period.
Follows a stable, consistent exercise regimen and are willing, for the duration of the study, to not decrease or increase the amount of exercise in their regimen.
Agrees to refrain from any lifestyle changes that may affect their menstrual cycle for the duration of the study (for example, getting on or off hormonal birth control, reducing the amount of exercise).
If using any other interventions, such as massage, chiropractic medicine, or acupuncture, agrees not to increase or decrease the number of these other interventions during the study period.
Resides in the United States.

Exclusion

Does not experience a regular menstrual cycle (21-35 days).
Does not experience menstrual cramping.
Follows an extreme diet intervention such as dry fasts, water fasts, or ketogenic diets.
Anyone who has experienced significant weight loss in the past three months prior to study participation.
Unwilling to stop the use of any medication or herbal remedies/supplements that can affect the menstrual cycle.
Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
Anyone with known severe allergic reactions.
Anyone with any allergies or sensitivities to any of the study product ingredients.
Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
Anyone unwilling to follow the study protocol.
Has stopped, started, or changed hormonal birth control in the past three months.
Previous users of Elix Cycle Balance.
Anyone who is currently a smoker or has been a smoker in the past 3 months.
Anyone who has been diagnosed with the following conditions: PCOS, Endometriosis, PMDD, Adenomyosis, Hashimoto's thyroiditis, Grave's disease (and any other thyroid disorders), hyperprolactinemia, Cushing's disease, congenital adrenal hyperplasia, anorexia, bulimia, orthorexia, binge eating, any other eating disorder.
History of endocrine disorders such as thyroid disorder, Type 1 or 2 diabetes, or other.
History of hypertension, hyperlipidemia, or previous venous embolism.
Overweight/obesity (BMI \> 25 kg/m2).
Women with other causes of chronic pelvic pain, including infectious disease, gastrointestinal, psychological disorders, fibromyalgia, and chronic fatigue syndrome.
Hysterectomy, myomectomy, or bilateral salpingo-oophorectomy or other gynecological medical or surgical treatment in the last 6 months.
History of an abnormal pap smear.
History of neoplasia of gynecological origin and/or existence of uterine malformations.
Chronic urinary tract infections or diagnosed functional gastrointestinal conditions like IBS, IBD, Crohn's disease, or ulcerative colitis.
Currently partaking in another research study or will be partaking in any other research study for the next 24 weeks, or at any point during this study's duration.
Consume more than 5 alcoholic drinks per week
Had a vaccine in the last 3 months

What this trial measures

  • Change in uterine fibroid-related symptom severityBaseline, Week 4, Week 8, Week 12, Week 16, Week 20, and Week 24

    Measured as change in menstrual pain and bleeding volume using the validated Uterine Fibroid Symptom Health-Related Quality of Life Questionnaire (UFS-QOL) total and subscale scores.